Search results for "Hepatocellular carcinoma"
USPSTF recommends screening adults 18 to 79 years for hepatitis C virus infection with moderate certainty
An essential requirement of expanded screening is the availability of effective treatment, but randomized controlled trials to date have not shown clinical benefit of direct-acting antiviral therapy beyond sustained virologic response, an ACP Journal Club commentary noted.
https://gastroenterology.acponline.org/archives/2020/07/24/7.htm
24 Jul 2020
Spotlight on The Liver Meeting
Highlights from the American Association for the Study of Liver Diseases' annual meeting, held virtually this past weekend, included insights on COVID-19 and the liver and a conversation with the winners of the Nobel Prize in Physiology or Medicine 2020, who discovered hepatitis C virus.
https://gastroenterology.acponline.org/archives/2020/11/20/5.htm
20 Nov 2020
Practice guidance addresses vascular liver disorders, portal vein thrombosis, procedural bleeding
Among other statements, the American Association for the Study of Liver Diseases said that modifiable risk factors for bleeding, such as use of antithrombotic drugs, should be identified and corrected before procedures in patients with cirrhosis.
https://gastroenterology.acponline.org/archives/2020/12/18/2.htm
18 Dec 2020
Antibiotic may prevent hepatic encephalopathy after TIPS in patients with cirrhosis
A French trial found that 34% of patients who received rifaximin before and after placement of a transjugular intrahepatic portosystemic shunt (TIPS) had hepatic encephalopathy versus 53% of those who received placebo, with no differences in adverse events or transplant-free survival.
https://gastroenterology.acponline.org/archives/2021/02/26/7.htm
26 Feb 2021
MKSAP Quiz: Management of HBV infection
This month's quiz asks readers to determine the most appropriate next step in management of a 29-year-old woman with hepatitis B virus (HBV) infection and normal liver enzyme levels.
https://gastroenterology.acponline.org/archives/2021/04/23/4.htm
23 Apr 2021
Treatment algorithm updated for chronic HBV
The recommendations address use of newer therapies and are intended to offer guidance on treating chronic hepatitis B virus (HBV) infection while additional antiviral agents are in development.
https://gastroenterology.acponline.org/archives/2021/08/27/1.htm
27 Aug 2021
MKSAP Quiz: Hepatocellular carcinoma surveillance after HCV treatment
This month's quiz asks readers to determine the most appropriate biannual surveillance modality for a 62-year-old patient with compensated cirrhosis who was treated for hepatitis C virus (HCV) infection six months ago.
https://gastroenterology.acponline.org/archives/2021/10/22/4.htm
22 Oct 2021
U.S. sees decrease in HCC disease burden
Incidence of hepatocellular carcinoma (HCC) decreased sharply by 2.3% annually after 2011, while incidence-based mortality saw a 3.2% annual decrease after 2013, according to a study based on national data.
https://gastroenterology.acponline.org/archives/2022/02/25/2.htm
25 Feb 2022
Aspirin use is associated with reduced risk for hepatocellular carcinoma
The findings of a recent meta-analysis provide support for an association between aspirin use and reduced risk for hepatocellular carcinoma but do not warrant use of aspirin as prophylaxis, and more research is needed, an ACP Journal Club commentary said.
https://gastroenterology.acponline.org/archives/2022/07/22/8.htm
22 Jul 2022
New guidance on diagnosis, management of acute hepatic porphyrias
These genetic errors of heme metabolism, although rare, appear to be more common than previously thought, and recent treatment advances have improved the outlook for patients with the diagnoses, according to the American Gastroenterological Association.
https://gastroenterology.acponline.org/archives/2023/01/27/1.htm
27 Jan 2023